APOTEA.ST Apotea

Healthcare Pharmaceutical Retailers Stockholm Exchange
104.30 SEK
Close of Nov 7, 2026
54.00 105.50
Market cap
SEK 10.9B
P/E
42.4x
P/B
10.39x
ROE
31.4%
Dividend yield
0.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is APOTEA.ST undervalued?

Graham number

The Graham number of Apotea cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Apotea fundamental analysis

No fundamental analysis for Apotea yet.

Apotea stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Apotea

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, s…

Full company profile